171 related articles for article (PubMed ID: 31401124)
21. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
Langaee T; Hamadeh I; Chapman AB; Gums JG; Johnson JA
PLoS One; 2015; 10(1):e0113808. PubMed ID: 25625348
[TBL] [Abstract][Full Text] [Related]
22. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
[TBL] [Abstract][Full Text] [Related]
23. CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project.
Gaedigk A; Boone EC; Scherer SE; Lee SB; Numanagić I; Sahinalp C; Smith JD; McGee S; Radhakrishnan A; Qin X; Wang WY; Farrow EG; Gonzaludo N; Halpern AL; Nickerson DA; Miller NA; Pratt VM; Kalman LV
J Mol Diagn; 2022 Apr; 24(4):337-350. PubMed ID: 35134542
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous detection of single nucleotide polymorphisms and copy number variations in the CYP2D6 gene by multiplex polymerase chain reaction combined with capillary electrophoresis.
Liao HW; Tsai IL; Chen GY; Kuo CT; Wei MF; Hwang TJ; Chen WJ; Shen LJ; Kuo CH
Anal Chim Acta; 2013 Feb; 763():67-75. PubMed ID: 23340288
[TBL] [Abstract][Full Text] [Related]
25. CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection.
Hosono N; Kato M; Kiyotani K; Mushiroda T; Takata S; Sato H; Amitani H; Tsuchiya Y; Yamazaki K; Tsunoda T; Zembutsu H; Nakamura Y; Kubo M
Clin Chem; 2009 Aug; 55(8):1546-54. PubMed ID: 19541866
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians.
Al-Dosari MS; Al-Jenoobi FI; Alkharfy KM; Alghamdi AM; Bagulb KM; Parvez MK; Al-Mohizea AM; Al-Muhsen S; Halwani R
Environ Toxicol Pharmacol; 2013 Nov; 36(3):1063-7. PubMed ID: 24121619
[TBL] [Abstract][Full Text] [Related]
27. CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene.
Skierka JM; Walker DL; Peterson SE; O'Kane DJ; Black JL
Pharmacogenomics; 2012 Jun; 13(8):951-4. PubMed ID: 22676198
[TBL] [Abstract][Full Text] [Related]
28. Postmortem CYP2D6 Genotyping and Copy Number Determinations Using DNA Extracted from Archived FTA Bloodstains.
Melis R; Mohamed J; Ha Y; Lyon E; McMillin G
J Anal Toxicol; 2019 Jun; 43(5):411-414. PubMed ID: 30855675
[TBL] [Abstract][Full Text] [Related]
29. Development of genomic reference materials for Huntington disease genetic testing.
Kalman L; Johnson MA; Beck J; Berry-Kravis E; Buller A; Casey B; Feldman GL; Handsfield J; Jakupciak JP; Maragh S; Matteson K; Muralidharan K; Richie KL; Rohlfs EM; Schaefer F; Sellers T; Spector E; Richards CS
Genet Med; 2007 Oct; 9(10):719-23. PubMed ID: 18073586
[TBL] [Abstract][Full Text] [Related]
30. Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
Chen X; Shen F; Gonzaludo N; Malhotra A; Rogert C; Taft RJ; Bentley DR; Eberle MA
Pharmacogenomics J; 2021 Apr; 21(2):251-261. PubMed ID: 33462347
[TBL] [Abstract][Full Text] [Related]
31. National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China.
Lin G; Zhang K; Yi L; Han Y; Xie J; Li J
PLoS One; 2016; 11(9):e0162361. PubMed ID: 27603206
[TBL] [Abstract][Full Text] [Related]
32. Long-Read Single Molecule Real-Time Full Gene Sequencing of Cytochrome P450-2D6.
Qiao W; Yang Y; Sebra R; Mendiratta G; Gaedigk A; Desnick RJ; Scott SA
Hum Mutat; 2016 Mar; 37(3):315-23. PubMed ID: 26602992
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Novel
Wang WY; Twesigomwe D; Nofziger C; Turner AJ; Helmecke LS; Broeckel U; Derezinski AD; Hazelhurst S; Gaedigk A
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294714
[TBL] [Abstract][Full Text] [Related]
34. Genotyping CYP2D6 by three different methods: advantages and disadvantages.
Ribeiro C; Martins P; Grazina M
Drug Metab Pers Ther; 2017 Mar; 32(1):33-37. PubMed ID: 28170339
[TBL] [Abstract][Full Text] [Related]
35. Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3, *4, and *6) within an Iranian population (Mazandaran).
Hashemi-Soteh SM; Sarzare F; Merat F; Salehifar E; Shiran MR
Genet Test Mol Biomarkers; 2011 Nov; 15(11):821-5. PubMed ID: 21631295
[TBL] [Abstract][Full Text] [Related]
36. Genotype and phenotype concordance for pharmacogenetic tests through proficiency survey testing.
Wu AH
Arch Pathol Lab Med; 2013 Sep; 137(9):1232-6. PubMed ID: 23991737
[TBL] [Abstract][Full Text] [Related]
37. Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.
Bousman CA; Jaksa P; Pantelis C
Pharmacogenet Genomics; 2017 Nov; 27(11):387-393. PubMed ID: 28777243
[TBL] [Abstract][Full Text] [Related]
38. Development of a tetraplex PCR assay for CYP2D6 genotyping in degraded DNA samples.
Riccardi LN; Lanzellotto R; Falconi M; Ceccardi S; Bini C; Pelotti S
J Forensic Sci; 2014 May; 59(3):690-5. PubMed ID: 24313823
[TBL] [Abstract][Full Text] [Related]
39. Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
Numanagić I; Malikić S; Pratt VM; Skaar TC; Flockhart DA; Sahinalp SC
Bioinformatics; 2015 Jun; 31(12):i27-34. PubMed ID: 26072492
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis.
Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
